Computer-assisted Vacuum Thrombectomy (CAVT) for Cancer Patients with Pulmonary Embolism

This study is looking at the safety and quality of life benefits of a procedure called Aspiration Thrombectomy for cancer patients who have an intermediate-risk pulmonary embolism (PE), which is a blood clot in the lung. You might be able to join if you are an adult with a current or past cancer diagnosis, have a confirmed PE, and are considered to have an intermediate-risk PE. The study will measure how your quality of life changes after the procedure, specifically looking at your ability to function. The study plans to enroll 25 participants, but its current recruitment status is unclear.

Study design
This is a single-center, single-arm study, meaning all participants will receive the same treatment. It plans to enroll 25 participants.
What's involved
The study will assess your quality of life at discharge and follow up with you for about one year to monitor safety and other outcomes.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed through study completion, which is an average of one year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07298096

A Prospective Single Center, Single Arm, Single-institution Registry That Aims to Assess the Safety and Quality of Life Benefits of Computer-assisted Vacuum Thrombectomy (CAVT) in the Treatment of Cancer Patients With Intermediate Risk Pulmonary Embolism (PE)

Recruiting
NAAges 18+InterventionalSupportive care
M.D. Anderson Cancer Center
~25 participants
Updated 2026-07-29 on ClinicalTrials.gov
What's tested:Aspiration Thrombectomy

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Safety and Adverse Events (AEs)
Measured over Through study completion; an average of 1 year
Cancer
1 sites across 1 states
Texas1
  • Varshana Gurusamy, MD · PRINCIPAL_INVESTIGATOR · M.D. Anderson Cancer Center

Opens a ready-to-send draft in your own email app — review before sending.

  • Safety and Adverse Events (AEs)Through study completion; an average of 1 year

    Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0